Help us endHIV
#ENDHIV has one mission: to fund the research and development of a promising new vaccine technology that has the potential to finally end the worldwide battle against HIV/AIDS.

In 2008, Dr. Sudhir Paul, a chemical immunologist from the University of Texas at Houston, announced his discovery of a novel way to destroy HIV.

newswk-dr-paulHis new HIV E-vaccine would teach the body to create Abzymes—electrically charged antibodies-that target and neutralize the non-mutating parts of the ever-changing HIV virus.  This new paradigm challenges much of the existing work in the field.  It was met with backlash from the scientific community. Peer reviewed grants from the National Institute of Health, which had funded Dr. Paul’s research with over $15 million, all but disappeared.

os-zach-barnett-endhivThat same year, Zachary Barnett, Founder and Executive Director of Abzyme Research Foundation (ARF), was diagnosed as HIV positive.

While researching treatment online, he came across a clip from CBS News on Dr. Paul’s work entitled “Possible HIV Cure.”  Inspired to take action, Barnett wrote Dr. Paul a small check and proposed throwing a fundraising event in New York City.  When Dr. Paul called him two weeks later, a partnership was formed.

The partnership between ARF and Dr. Paul  has grown over the years into a coalition of world-class doctors and scientists, dedicated activists and artists — people willing to take a stand for our future by raising awareness and funds for this vital research. The scientific team, lead by Dr. Paul, has developed the only vaccine candidate documented to produce broadly neutralizing antibodies that are effective against most strains of HIV. Our HIV E-Vaccine is now one step away from FDA permission to begin human trials.

os-scr-1-2
os-scr-2-3
os-scr-3-2
os-scr-4-2
Dr Paul Time Magazine
Just like Dr. Paul’s E-vaccine, Jonas Salk’s Polio vaccine was first dismissed because it was outside of the mainstream.

We believe challenging accepted ideas is the only way to find new solutions.

Many great scientific advances were met with initial skepticism. Just like Dr. Paul’s E-vaccine, Jonas Salk’s Polio vaccine was first dismissed because it was outside of the mainstream. It was everyday citizens who came together and formed The March of Dimes, a grassroots nonprofit dedicated funding Salk’s research. They backed the largest field test in human history which led to the development of a successful Polio vaccine. This is exactly the kind of unified and generous effort we are asking people to join now in order to #endHIV.

Although medicines now exist that help people to live longer and more safely with HIV and AIDS, the reality is that no one should have to rely on an expensive daily pill to keep them alive. The quality of life with HIV varies drastically between the haves and have nots.

os-skireli
No one should have to rely on an expensive daily pill to keep them alive. The quality of life with HIV varies drastically between the haves and have nots.

For those with access to care, HIV is a manageable, chronic condition. For those without it, HIV is a death sentence.

We need a scalable solution, accessible to those who need it most across the globe.

ARF’s partnership with CoBio, Dr. Paul’s for-profit company, represents a for-profit/non-profit structure that will uniquely position our HIV E-vaccine to be sold and distributed in a way that will provide access to treatment and prevention for all.

Help us #endHIV by ensuring Dr. Paul’s breakthrough research is brought to fruition and that the resulting E-vaccine becomes readily available to everyone.

Our Commitment to #endHIV

bod-song-3
“I am proud to be a leader of the #endHIV campaign, to be part of a generation and an organization that will for once and for all rid this horrible disease from mankind.”
bod-kerr-3
“I’m excited and proud to be a part of a project so groundbreaking, it will change lives. A pivotal revolution in science.”
bod-miller-3
“As an infectious disease physician and researcher that studies HIV therapeutic vaccines, I am motivated by efforts to expand our horizons beyond current paradigms. I joined the board of ARF because the research it supports does just this.”

Your donation will fund two vital
steps before human trials:

First, manufacturing our E-vaccine at scale; second, the final
proposal process for FDA approval of human trials.

btn-donate-upd

$250 K $1.25 MM

Thanks to the generous support of private donors underwriting our campaign, 100% of your donation will go directly to supporting this HIV/AIDS cure research.

Click here to see how we use our funding.

os-science2

os-videos

Top